Inhibition of angiogenesis by a new isocoumarin, NM-3.
Nakashima
T
T
Hirano
S
S
Agata
N
N
Kumagai
H
H
Isshiki
K
K
Yoshioka
T
T
Ishizuka
M
M
Maeda
K
K
Takeuchi
T
T
D000818:Animals; D000925:Anticoagulants / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D003374:Coumarins / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D015194:Diffusion Chambers, Culture; D004305:Dose-Response Relationship, Drug; D005260:Female; D049934:Isocoumarins; D051379:Mice; D008813:Mice, Inbred ICR; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000473:pathology; D014407:Tumor Cells, Cultured
D000925:Anticoagulants; D000970:Antineoplastic Agents; D003374:Coumarins; D049934:Isocoumarins; C453300:isocoumarin NM-3; C066806:cytogenin